nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ABCB1—Tacrolimus—atopic dermatitis	0.136	0.231	CbGbCtD
Nadolol—ABCB1—Loratadine—atopic dermatitis	0.0998	0.169	CbGbCtD
Nadolol—ABCB1—Methylprednisolone—atopic dermatitis	0.0913	0.155	CbGbCtD
Nadolol—ABCB1—Betamethasone—atopic dermatitis	0.0594	0.1	CbGbCtD
Nadolol—ABCB1—Prednisolone—atopic dermatitis	0.0586	0.0991	CbGbCtD
Nadolol—ABCB1—Hydrocortisone—atopic dermatitis	0.0555	0.094	CbGbCtD
Nadolol—ABCB1—Prednisone—atopic dermatitis	0.0553	0.0936	CbGbCtD
Nadolol—ABCB1—Dexamethasone—atopic dermatitis	0.0345	0.0585	CbGbCtD
Nadolol—Loss of consciousness—Tacrolimus—atopic dermatitis	0.000682	0.00169	CcSEcCtD
Nadolol—Pain—Mometasone—atopic dermatitis	0.00068	0.00169	CcSEcCtD
Nadolol—Cough—Tacrolimus—atopic dermatitis	0.000677	0.00168	CcSEcCtD
Nadolol—Affect lability—Dexamethasone—atopic dermatitis	0.000676	0.00168	CcSEcCtD
Nadolol—Affect lability—Betamethasone—atopic dermatitis	0.000676	0.00168	CcSEcCtD
Nadolol—Hypertension—Tacrolimus—atopic dermatitis	0.00067	0.00166	CcSEcCtD
Nadolol—Asthenia—Loratadine—atopic dermatitis	0.000665	0.00165	CcSEcCtD
Nadolol—Chest pain—Tacrolimus—atopic dermatitis	0.00066	0.00164	CcSEcCtD
Nadolol—Cardiac failure congestive—Prednisone—atopic dermatitis	0.000659	0.00164	CcSEcCtD
Nadolol—Body temperature increased—Fluocinolone Acetonide—atopic dermatitis	0.000659	0.00164	CcSEcCtD
Nadolol—Abdominal distension—Triamcinolone—atopic dermatitis	0.000658	0.00164	CcSEcCtD
Nadolol—Abdominal distension—Methylprednisolone—atopic dermatitis	0.000657	0.00163	CcSEcCtD
Nadolol—Irritability—Dexamethasone—atopic dermatitis	0.000655	0.00163	CcSEcCtD
Nadolol—Irritability—Betamethasone—atopic dermatitis	0.000655	0.00163	CcSEcCtD
Nadolol—Mood swings—Betamethasone—atopic dermatitis	0.00065	0.00162	CcSEcCtD
Nadolol—Mood swings—Dexamethasone—atopic dermatitis	0.00065	0.00162	CcSEcCtD
Nadolol—Weight increased—Prednisolone—atopic dermatitis	0.000647	0.00161	CcSEcCtD
Nadolol—Dry mouth—Tacrolimus—atopic dermatitis	0.000646	0.0016	CcSEcCtD
Nadolol—Bronchospasm—Methylprednisolone—atopic dermatitis	0.000642	0.00159	CcSEcCtD
Nadolol—Amnesia—Prednisone—atopic dermatitis	0.000636	0.00158	CcSEcCtD
Nadolol—Diarrhoea—Loratadine—atopic dermatitis	0.000634	0.00158	CcSEcCtD
Nadolol—Oedema—Tacrolimus—atopic dermatitis	0.000633	0.00157	CcSEcCtD
Nadolol—Weight increased—Hydrocortisone—atopic dermatitis	0.000632	0.00157	CcSEcCtD
Nadolol—Dry skin—Betamethasone—atopic dermatitis	0.000629	0.00156	CcSEcCtD
Nadolol—Dry skin—Dexamethasone—atopic dermatitis	0.000629	0.00156	CcSEcCtD
Nadolol—Body temperature increased—Mometasone—atopic dermatitis	0.000629	0.00156	CcSEcCtD
Nadolol—Shock—Tacrolimus—atopic dermatitis	0.000623	0.00155	CcSEcCtD
Nadolol—Conjunctivitis—Prednisolone—atopic dermatitis	0.000616	0.00153	CcSEcCtD
Nadolol—Dizziness—Loratadine—atopic dermatitis	0.000613	0.00152	CcSEcCtD
Nadolol—Cardiac failure—Prednisone—atopic dermatitis	0.000613	0.00152	CcSEcCtD
Nadolol—Hyperhidrosis—Tacrolimus—atopic dermatitis	0.000612	0.00152	CcSEcCtD
Nadolol—Lethargy—Prednisone—atopic dermatitis	0.00061	0.00152	CcSEcCtD
Nadolol—Anorexia—Tacrolimus—atopic dermatitis	0.000604	0.0015	CcSEcCtD
Nadolol—Weight increased—Triamcinolone—atopic dermatitis	0.000595	0.00148	CcSEcCtD
Nadolol—Weight increased—Methylprednisolone—atopic dermatitis	0.000594	0.00148	CcSEcCtD
Nadolol—Hypotension—Tacrolimus—atopic dermatitis	0.000592	0.00147	CcSEcCtD
Nadolol—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.000589	0.00146	CcSEcCtD
Nadolol—Vomiting—Loratadine—atopic dermatitis	0.000589	0.00146	CcSEcCtD
Nadolol—Affect lability—Prednisone—atopic dermatitis	0.000589	0.00146	CcSEcCtD
Nadolol—Rash—Loratadine—atopic dermatitis	0.000584	0.00145	CcSEcCtD
Nadolol—Dermatitis—Loratadine—atopic dermatitis	0.000584	0.00145	CcSEcCtD
Nadolol—Bradycardia—Prednisolone—atopic dermatitis	0.000579	0.00144	CcSEcCtD
Nadolol—Insomnia—Tacrolimus—atopic dermatitis	0.000573	0.00142	CcSEcCtD
Nadolol—Asthenia—Mometasone—atopic dermatitis	0.000571	0.00142	CcSEcCtD
Nadolol—Irritability—Prednisone—atopic dermatitis	0.000571	0.00142	CcSEcCtD
Nadolol—Diarrhoea—Fluocinolone Acetonide—atopic dermatitis	0.00057	0.00142	CcSEcCtD
Nadolol—Paraesthesia—Tacrolimus—atopic dermatitis	0.000569	0.00141	CcSEcCtD
Nadolol—Conjunctivitis—Triamcinolone—atopic dermatitis	0.000567	0.00141	CcSEcCtD
Nadolol—Mood swings—Prednisone—atopic dermatitis	0.000566	0.00141	CcSEcCtD
Nadolol—Bradycardia—Hydrocortisone—atopic dermatitis	0.000566	0.00141	CcSEcCtD
Nadolol—Dyspnoea—Tacrolimus—atopic dermatitis	0.000564	0.0014	CcSEcCtD
Nadolol—Pruritus—Mometasone—atopic dermatitis	0.000563	0.0014	CcSEcCtD
Nadolol—Sweating—Methylprednisolone—atopic dermatitis	0.000558	0.00139	CcSEcCtD
Nadolol—Dyspepsia—Tacrolimus—atopic dermatitis	0.000557	0.00138	CcSEcCtD
Nadolol—Hallucination—Hydrocortisone—atopic dermatitis	0.000553	0.00137	CcSEcCtD
Nadolol—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.000551	0.00137	CcSEcCtD
Nadolol—Nausea—Loratadine—atopic dermatitis	0.000551	0.00137	CcSEcCtD
Nadolol—Decreased appetite—Tacrolimus—atopic dermatitis	0.00055	0.00137	CcSEcCtD
Nadolol—Visual impairment—Prednisolone—atopic dermatitis	0.000549	0.00136	CcSEcCtD
Nadolol—Dry skin—Prednisone—atopic dermatitis	0.000548	0.00136	CcSEcCtD
Nadolol—Fatigue—Tacrolimus—atopic dermatitis	0.000546	0.00136	CcSEcCtD
Nadolol—Diarrhoea—Mometasone—atopic dermatitis	0.000544	0.00135	CcSEcCtD
Nadolol—Pain—Tacrolimus—atopic dermatitis	0.000541	0.00135	CcSEcCtD
Nadolol—Constipation—Tacrolimus—atopic dermatitis	0.000541	0.00135	CcSEcCtD
Nadolol—Weight increased—Dexamethasone—atopic dermatitis	0.00054	0.00134	CcSEcCtD
Nadolol—Weight increased—Betamethasone—atopic dermatitis	0.00054	0.00134	CcSEcCtD
Nadolol—Bradycardia—Triamcinolone—atopic dermatitis	0.000533	0.00132	CcSEcCtD
Nadolol—Bradycardia—Methylprednisolone—atopic dermatitis	0.000532	0.00132	CcSEcCtD
Nadolol—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00053	0.00132	CcSEcCtD
Nadolol—Rash—Fluocinolone Acetonide—atopic dermatitis	0.000525	0.0013	CcSEcCtD
Nadolol—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.000525	0.0013	CcSEcCtD
Nadolol—Abdominal distension—Prednisone—atopic dermatitis	0.00052	0.00129	CcSEcCtD
Nadolol—Hallucination—Methylprednisolone—atopic dermatitis	0.00052	0.00129	CcSEcCtD
Nadolol—Conjunctivitis—Dexamethasone—atopic dermatitis	0.000514	0.00128	CcSEcCtD
Nadolol—Conjunctivitis—Betamethasone—atopic dermatitis	0.000514	0.00128	CcSEcCtD
Nadolol—Vomiting—Mometasone—atopic dermatitis	0.000506	0.00126	CcSEcCtD
Nadolol—Visual impairment—Methylprednisolone—atopic dermatitis	0.000503	0.00125	CcSEcCtD
Nadolol—Rash—Mometasone—atopic dermatitis	0.000502	0.00125	CcSEcCtD
Nadolol—Dermatitis—Mometasone—atopic dermatitis	0.000501	0.00124	CcSEcCtD
Nadolol—Body temperature increased—Tacrolimus—atopic dermatitis	0.000501	0.00124	CcSEcCtD
Nadolol—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.000495	0.00123	CcSEcCtD
Nadolol—Bradycardia—Betamethasone—atopic dermatitis	0.000484	0.0012	CcSEcCtD
Nadolol—Bradycardia—Dexamethasone—atopic dermatitis	0.000484	0.0012	CcSEcCtD
Nadolol—Erectile dysfunction—Prednisone—atopic dermatitis	0.000476	0.00118	CcSEcCtD
Nadolol—Hallucination—Betamethasone—atopic dermatitis	0.000473	0.00117	CcSEcCtD
Nadolol—Hallucination—Dexamethasone—atopic dermatitis	0.000473	0.00117	CcSEcCtD
Nadolol—Nausea—Mometasone—atopic dermatitis	0.000473	0.00117	CcSEcCtD
Nadolol—Weight increased—Prednisone—atopic dermatitis	0.00047	0.00117	CcSEcCtD
Nadolol—Vision blurred—Prednisolone—atopic dermatitis	0.000467	0.00116	CcSEcCtD
Nadolol—Depression—Prednisone—atopic dermatitis	0.000459	0.00114	CcSEcCtD
Nadolol—Visual impairment—Dexamethasone—atopic dermatitis	0.000458	0.00114	CcSEcCtD
Nadolol—Visual impairment—Betamethasone—atopic dermatitis	0.000458	0.00114	CcSEcCtD
Nadolol—Asthenia—Tacrolimus—atopic dermatitis	0.000454	0.00113	CcSEcCtD
Nadolol—Pruritus—Tacrolimus—atopic dermatitis	0.000448	0.00111	CcSEcCtD
Nadolol—Syncope—Prednisolone—atopic dermatitis	0.000444	0.0011	CcSEcCtD
Nadolol—Loss of consciousness—Prednisolone—atopic dermatitis	0.000436	0.00108	CcSEcCtD
Nadolol—Syncope—Hydrocortisone—atopic dermatitis	0.000434	0.00108	CcSEcCtD
Nadolol—Diarrhoea—Tacrolimus—atopic dermatitis	0.000433	0.00108	CcSEcCtD
Nadolol—Hypertension—Prednisolone—atopic dermatitis	0.000428	0.00106	CcSEcCtD
Nadolol—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.000425	0.00106	CcSEcCtD
Nadolol—Bradycardia—Prednisone—atopic dermatitis	0.000421	0.00105	CcSEcCtD
Nadolol—Alopecia—Betamethasone—atopic dermatitis	0.00042	0.00104	CcSEcCtD
Nadolol—Alopecia—Dexamethasone—atopic dermatitis	0.00042	0.00104	CcSEcCtD
Nadolol—Dizziness—Tacrolimus—atopic dermatitis	0.000419	0.00104	CcSEcCtD
Nadolol—Hypertension—Hydrocortisone—atopic dermatitis	0.000418	0.00104	CcSEcCtD
Nadolol—Hallucination—Prednisone—atopic dermatitis	0.000412	0.00102	CcSEcCtD
Nadolol—Syncope—Triamcinolone—atopic dermatitis	0.000409	0.00102	CcSEcCtD
Nadolol—Syncope—Methylprednisolone—atopic dermatitis	0.000408	0.00101	CcSEcCtD
Nadolol—Oedema—Prednisolone—atopic dermatitis	0.000404	0.001	CcSEcCtD
Nadolol—Vomiting—Tacrolimus—atopic dermatitis	0.000403	0.001	CcSEcCtD
Nadolol—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000401	0.000995	CcSEcCtD
Nadolol—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.0004	0.000993	CcSEcCtD
Nadolol—Rash—Tacrolimus—atopic dermatitis	0.000399	0.000992	CcSEcCtD
Nadolol—Dermatitis—Tacrolimus—atopic dermatitis	0.000399	0.000991	CcSEcCtD
Nadolol—Shock—Prednisolone—atopic dermatitis	0.000398	0.000988	CcSEcCtD
Nadolol—Cough—Triamcinolone—atopic dermatitis	0.000398	0.000988	CcSEcCtD
Nadolol—Oedema—Hydrocortisone—atopic dermatitis	0.000395	0.000981	CcSEcCtD
Nadolol—Hypertension—Triamcinolone—atopic dermatitis	0.000393	0.000977	CcSEcCtD
Nadolol—Hypertension—Methylprednisolone—atopic dermatitis	0.000393	0.000975	CcSEcCtD
Nadolol—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000391	0.000971	CcSEcCtD
Nadolol—Shock—Hydrocortisone—atopic dermatitis	0.000389	0.000965	CcSEcCtD
Nadolol—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.000382	0.000949	CcSEcCtD
Nadolol—Dry mouth—Triamcinolone—atopic dermatitis	0.000379	0.000943	CcSEcCtD
Nadolol—Anorexia—Hydrocortisone—atopic dermatitis	0.000376	0.000935	CcSEcCtD
Nadolol—Nausea—Tacrolimus—atopic dermatitis	0.000376	0.000934	CcSEcCtD
Nadolol—Oedema—Triamcinolone—atopic dermatitis	0.000372	0.000924	CcSEcCtD
Nadolol—Syncope—Dexamethasone—atopic dermatitis	0.000371	0.000921	CcSEcCtD
Nadolol—Syncope—Betamethasone—atopic dermatitis	0.000371	0.000921	CcSEcCtD
Nadolol—Hypotension—Hydrocortisone—atopic dermatitis	0.000369	0.000917	CcSEcCtD
Nadolol—Shock—Triamcinolone—atopic dermatitis	0.000366	0.000909	CcSEcCtD
Nadolol—Insomnia—Prednisolone—atopic dermatitis	0.000366	0.000909	CcSEcCtD
Nadolol—Alopecia—Prednisone—atopic dermatitis	0.000366	0.000908	CcSEcCtD
Nadolol—Shock—Methylprednisolone—atopic dermatitis	0.000365	0.000907	CcSEcCtD
Nadolol—Loss of consciousness—Betamethasone—atopic dermatitis	0.000363	0.000903	CcSEcCtD
Nadolol—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000363	0.000903	CcSEcCtD
Nadolol—Paraesthesia—Prednisolone—atopic dermatitis	0.000363	0.000902	CcSEcCtD
Nadolol—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.00036	0.000893	CcSEcCtD
Nadolol—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000359	0.000891	CcSEcCtD
Nadolol—Insomnia—Hydrocortisone—atopic dermatitis	0.000357	0.000887	CcSEcCtD
Nadolol—Hypertension—Dexamethasone—atopic dermatitis	0.000357	0.000887	CcSEcCtD
Nadolol—Hypertension—Betamethasone—atopic dermatitis	0.000357	0.000887	CcSEcCtD
Nadolol—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000355	0.000881	CcSEcCtD
Nadolol—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000348	0.000864	CcSEcCtD
Nadolol—Hypotension—Methylprednisolone—atopic dermatitis	0.000347	0.000861	CcSEcCtD
Nadolol—Pain—Prednisolone—atopic dermatitis	0.000346	0.000859	CcSEcCtD
Nadolol—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000343	0.000853	CcSEcCtD
Nadolol—Fatigue—Hydrocortisone—atopic dermatitis	0.000341	0.000846	CcSEcCtD
Nadolol—Vision blurred—Prednisone—atopic dermatitis	0.000339	0.000843	CcSEcCtD
Nadolol—Pain—Hydrocortisone—atopic dermatitis	0.000338	0.000839	CcSEcCtD
Nadolol—Oedema—Dexamethasone—atopic dermatitis	0.000337	0.000838	CcSEcCtD
Nadolol—Oedema—Betamethasone—atopic dermatitis	0.000337	0.000838	CcSEcCtD
Nadolol—Insomnia—Triamcinolone—atopic dermatitis	0.000336	0.000836	CcSEcCtD
Nadolol—Insomnia—Methylprednisolone—atopic dermatitis	0.000336	0.000834	CcSEcCtD
Nadolol—Paraesthesia—Triamcinolone—atopic dermatitis	0.000334	0.00083	CcSEcCtD
Nadolol—Paraesthesia—Methylprednisolone—atopic dermatitis	0.000333	0.000828	CcSEcCtD
Nadolol—Shock—Dexamethasone—atopic dermatitis	0.000332	0.000825	CcSEcCtD
Nadolol—Shock—Betamethasone—atopic dermatitis	0.000332	0.000825	CcSEcCtD
Nadolol—Dyspnoea—Triamcinolone—atopic dermatitis	0.000332	0.000824	CcSEcCtD
Nadolol—Dyspepsia—Triamcinolone—atopic dermatitis	0.000327	0.000813	CcSEcCtD
Nadolol—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000327	0.000811	CcSEcCtD
Nadolol—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000326	0.00081	CcSEcCtD
Nadolol—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000326	0.00081	CcSEcCtD
Nadolol—Syncope—Prednisone—atopic dermatitis	0.000323	0.000802	CcSEcCtD
Nadolol—Anorexia—Dexamethasone—atopic dermatitis	0.000322	0.000799	CcSEcCtD
Nadolol—Anorexia—Betamethasone—atopic dermatitis	0.000322	0.000799	CcSEcCtD
Nadolol—Fatigue—Triamcinolone—atopic dermatitis	0.000321	0.000797	CcSEcCtD
Nadolol—Fatigue—Methylprednisolone—atopic dermatitis	0.00032	0.000795	CcSEcCtD
Nadolol—Pain—Triamcinolone—atopic dermatitis	0.000318	0.00079	CcSEcCtD
Nadolol—Loss of consciousness—Prednisone—atopic dermatitis	0.000316	0.000786	CcSEcCtD
Nadolol—Hypotension—Dexamethasone—atopic dermatitis	0.000315	0.000783	CcSEcCtD
Nadolol—Hypotension—Betamethasone—atopic dermatitis	0.000315	0.000783	CcSEcCtD
Nadolol—Body temperature increased—Hydrocortisone—atopic dermatitis	0.000312	0.000776	CcSEcCtD
Nadolol—Hypertension—Prednisone—atopic dermatitis	0.000311	0.000772	CcSEcCtD
Nadolol—Insomnia—Betamethasone—atopic dermatitis	0.000305	0.000758	CcSEcCtD
Nadolol—Insomnia—Dexamethasone—atopic dermatitis	0.000305	0.000758	CcSEcCtD
Nadolol—Paraesthesia—Betamethasone—atopic dermatitis	0.000303	0.000753	CcSEcCtD
Nadolol—Paraesthesia—Dexamethasone—atopic dermatitis	0.000303	0.000753	CcSEcCtD
Nadolol—Dyspepsia—Dexamethasone—atopic dermatitis	0.000297	0.000738	CcSEcCtD
Nadolol—Dyspepsia—Betamethasone—atopic dermatitis	0.000297	0.000738	CcSEcCtD
Nadolol—Body temperature increased—Triamcinolone—atopic dermatitis	0.000294	0.00073	CcSEcCtD
Nadolol—Oedema—Prednisone—atopic dermatitis	0.000294	0.00073	CcSEcCtD
Nadolol—Decreased appetite—Dexamethasone—atopic dermatitis	0.000293	0.000729	CcSEcCtD
Nadolol—Decreased appetite—Betamethasone—atopic dermatitis	0.000293	0.000729	CcSEcCtD
Nadolol—Fatigue—Dexamethasone—atopic dermatitis	0.000291	0.000723	CcSEcCtD
Nadolol—Fatigue—Betamethasone—atopic dermatitis	0.000291	0.000723	CcSEcCtD
Nadolol—Shock—Prednisone—atopic dermatitis	0.000289	0.000718	CcSEcCtD
Nadolol—Pain—Betamethasone—atopic dermatitis	0.000289	0.000717	CcSEcCtD
Nadolol—Pain—Dexamethasone—atopic dermatitis	0.000289	0.000717	CcSEcCtD
Nadolol—Hyperhidrosis—Prednisone—atopic dermatitis	0.000284	0.000706	CcSEcCtD
Nadolol—Asthenia—Hydrocortisone—atopic dermatitis	0.000283	0.000704	CcSEcCtD
Nadolol—Anorexia—Prednisone—atopic dermatitis	0.00028	0.000696	CcSEcCtD
Nadolol—Pruritus—Hydrocortisone—atopic dermatitis	0.000279	0.000694	CcSEcCtD
Nadolol—Diarrhoea—Hydrocortisone—atopic dermatitis	0.00027	0.000671	CcSEcCtD
Nadolol—Dizziness—Prednisolone—atopic dermatitis	0.000267	0.000664	CcSEcCtD
Nadolol—Asthenia—Triamcinolone—atopic dermatitis	0.000267	0.000663	CcSEcCtD
Nadolol—Body temperature increased—Dexamethasone—atopic dermatitis	0.000267	0.000663	CcSEcCtD
Nadolol—Body temperature increased—Betamethasone—atopic dermatitis	0.000267	0.000663	CcSEcCtD
Nadolol—Asthenia—Methylprednisolone—atopic dermatitis	0.000266	0.000661	CcSEcCtD
Nadolol—Insomnia—Prednisone—atopic dermatitis	0.000266	0.00066	CcSEcCtD
Nadolol—Paraesthesia—Prednisone—atopic dermatitis	0.000264	0.000656	CcSEcCtD
Nadolol—Pruritus—Triamcinolone—atopic dermatitis	0.000263	0.000654	CcSEcCtD
Nadolol—Pruritus—Methylprednisolone—atopic dermatitis	0.000263	0.000652	CcSEcCtD
Nadolol—Dizziness—Hydrocortisone—atopic dermatitis	0.000261	0.000649	CcSEcCtD
Nadolol—Dyspepsia—Prednisone—atopic dermatitis	0.000259	0.000643	CcSEcCtD
Nadolol—Decreased appetite—Prednisone—atopic dermatitis	0.000255	0.000635	CcSEcCtD
Nadolol—Rash—Prednisolone—atopic dermatitis	0.000255	0.000633	CcSEcCtD
Nadolol—Dermatitis—Prednisolone—atopic dermatitis	0.000255	0.000633	CcSEcCtD
Nadolol—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000254	0.000631	CcSEcCtD
Nadolol—Fatigue—Prednisone—atopic dermatitis	0.000253	0.000629	CcSEcCtD
Nadolol—Constipation—Prednisone—atopic dermatitis	0.000251	0.000624	CcSEcCtD
Nadolol—Vomiting—Hydrocortisone—atopic dermatitis	0.000251	0.000624	CcSEcCtD
Nadolol—Rash—Hydrocortisone—atopic dermatitis	0.000249	0.000619	CcSEcCtD
Nadolol—Dermatitis—Hydrocortisone—atopic dermatitis	0.000249	0.000618	CcSEcCtD
Nadolol—Dizziness—Triamcinolone—atopic dermatitis	0.000246	0.000611	CcSEcCtD
Nadolol—Dizziness—Methylprednisolone—atopic dermatitis	0.000245	0.00061	CcSEcCtD
Nadolol—Asthenia—Dexamethasone—atopic dermatitis	0.000242	0.000601	CcSEcCtD
Nadolol—Asthenia—Betamethasone—atopic dermatitis	0.000242	0.000601	CcSEcCtD
Nadolol—Nausea—Prednisolone—atopic dermatitis	0.00024	0.000597	CcSEcCtD
Nadolol—Pruritus—Betamethasone—atopic dermatitis	0.000239	0.000593	CcSEcCtD
Nadolol—Pruritus—Dexamethasone—atopic dermatitis	0.000239	0.000593	CcSEcCtD
Nadolol—Vomiting—Triamcinolone—atopic dermatitis	0.000236	0.000587	CcSEcCtD
Nadolol—Vomiting—Methylprednisolone—atopic dermatitis	0.000236	0.000586	CcSEcCtD
Nadolol—Nausea—Hydrocortisone—atopic dermatitis	0.000235	0.000583	CcSEcCtD
Nadolol—Rash—Triamcinolone—atopic dermatitis	0.000234	0.000583	CcSEcCtD
Nadolol—Dermatitis—Triamcinolone—atopic dermatitis	0.000234	0.000582	CcSEcCtD
Nadolol—Rash—Methylprednisolone—atopic dermatitis	0.000234	0.000581	CcSEcCtD
Nadolol—Dermatitis—Methylprednisolone—atopic dermatitis	0.000234	0.000581	CcSEcCtD
Nadolol—Body temperature increased—Prednisone—atopic dermatitis	0.000232	0.000577	CcSEcCtD
Nadolol—Diarrhoea—Betamethasone—atopic dermatitis	0.000231	0.000574	CcSEcCtD
Nadolol—Diarrhoea—Dexamethasone—atopic dermatitis	0.000231	0.000574	CcSEcCtD
Nadolol—Dizziness—Dexamethasone—atopic dermatitis	0.000223	0.000554	CcSEcCtD
Nadolol—Dizziness—Betamethasone—atopic dermatitis	0.000223	0.000554	CcSEcCtD
Nadolol—Nausea—Triamcinolone—atopic dermatitis	0.000221	0.000549	CcSEcCtD
Nadolol—Nausea—Methylprednisolone—atopic dermatitis	0.00022	0.000548	CcSEcCtD
Nadolol—Vomiting—Dexamethasone—atopic dermatitis	0.000215	0.000533	CcSEcCtD
Nadolol—Vomiting—Betamethasone—atopic dermatitis	0.000215	0.000533	CcSEcCtD
Nadolol—Rash—Betamethasone—atopic dermatitis	0.000213	0.000529	CcSEcCtD
Nadolol—Rash—Dexamethasone—atopic dermatitis	0.000213	0.000529	CcSEcCtD
Nadolol—Dermatitis—Dexamethasone—atopic dermatitis	0.000213	0.000528	CcSEcCtD
Nadolol—Dermatitis—Betamethasone—atopic dermatitis	0.000213	0.000528	CcSEcCtD
Nadolol—Asthenia—Prednisone—atopic dermatitis	0.000211	0.000524	CcSEcCtD
Nadolol—Pruritus—Prednisone—atopic dermatitis	0.000208	0.000517	CcSEcCtD
Nadolol—Diarrhoea—Prednisone—atopic dermatitis	0.000201	0.000499	CcSEcCtD
Nadolol—Nausea—Dexamethasone—atopic dermatitis	0.0002	0.000498	CcSEcCtD
Nadolol—Nausea—Betamethasone—atopic dermatitis	0.0002	0.000498	CcSEcCtD
Nadolol—Dizziness—Prednisone—atopic dermatitis	0.000194	0.000483	CcSEcCtD
Nadolol—Vomiting—Prednisone—atopic dermatitis	0.000187	0.000464	CcSEcCtD
Nadolol—Rash—Prednisone—atopic dermatitis	0.000185	0.00046	CcSEcCtD
Nadolol—Dermatitis—Prednisone—atopic dermatitis	0.000185	0.00046	CcSEcCtD
Nadolol—Nausea—Prednisone—atopic dermatitis	0.000175	0.000434	CcSEcCtD
Nadolol—ADRB3—GPCR ligand binding—CCL22—atopic dermatitis	9.76e-05	0.0147	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Other—CXCR3—atopic dermatitis	9.18e-05	0.0138	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCL27—atopic dermatitis	8.7e-05	0.0131	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	8.26e-05	0.0124	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	7.86e-05	0.0118	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCL17—atopic dermatitis	7.8e-05	0.0117	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	7.61e-05	0.0115	CbGpPWpGaD
Nadolol—ADRB1—G alpha (s) signalling events—NPS—atopic dermatitis	7.47e-05	0.0112	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	7.44e-05	0.0112	CbGpPWpGaD
Nadolol—ADRB2—G alpha (s) signalling events—NPS—atopic dermatitis	7.31e-05	0.011	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—FOXP3—atopic dermatitis	7.07e-05	0.0107	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	6.87e-05	0.0103	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	6.78e-05	0.0102	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	6.73e-05	0.0101	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	6.63e-05	0.00999	CbGpPWpGaD
Nadolol—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	6.44e-05	0.0097	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCL11—atopic dermatitis	6.29e-05	0.00947	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	6.08e-05	0.00916	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL13—atopic dermatitis	6.05e-05	0.00911	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	6e-05	0.00904	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	6e-05	0.00904	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	5.95e-05	0.00896	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	5.88e-05	0.00886	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCL22—atopic dermatitis	5.79e-05	0.00872	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Other—CCR5—atopic dermatitis	5.75e-05	0.00866	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL22—atopic dermatitis	5.67e-05	0.00853	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL17A—atopic dermatitis	5.57e-05	0.00839	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL5—atopic dermatitis	5.18e-05	0.0078	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCL27—atopic dermatitis	5.16e-05	0.00777	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCR3—atopic dermatitis	5.13e-05	0.00772	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL27—atopic dermatitis	5.05e-05	0.00761	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL22—atopic dermatitis	5.01e-05	0.00754	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CCL27—atopic dermatitis	4.91e-05	0.0074	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	4.9e-05	0.00738	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	4.79e-05	0.00722	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	4.76e-05	0.00716	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	4.66e-05	0.00702	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCL17—atopic dermatitis	4.63e-05	0.00697	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—TAC1—atopic dermatitis	4.57e-05	0.00688	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—NPS—atopic dermatitis	4.57e-05	0.00688	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	4.56e-05	0.00687	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL17—atopic dermatitis	4.53e-05	0.00682	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCR3—atopic dermatitis	4.48e-05	0.00675	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL27—atopic dermatitis	4.46e-05	0.00672	CbGpPWpGaD
Nadolol—ADRB3—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	4.3e-05	0.00648	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	4.09e-05	0.00617	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	4.08e-05	0.00614	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL17—atopic dermatitis	4e-05	0.00603	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	4e-05	0.00602	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	3.99e-05	0.00601	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	3.91e-05	0.00589	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL10—atopic dermatitis	3.79e-05	0.0057	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCL11—atopic dermatitis	3.73e-05	0.00562	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	3.69e-05	0.00555	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL4—atopic dermatitis	3.68e-05	0.00555	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL11—atopic dermatitis	3.65e-05	0.0055	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCL10—atopic dermatitis	3.62e-05	0.00545	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	3.62e-05	0.00545	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	3.56e-05	0.00536	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	3.56e-05	0.00536	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	3.49e-05	0.00526	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	3.48e-05	0.00525	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	3.48e-05	0.00525	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	3.42e-05	0.00514	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL11—atopic dermatitis	3.23e-05	0.00486	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—FCER2—atopic dermatitis	3.18e-05	0.00479	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCL5—atopic dermatitis	3.12e-05	0.0047	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCR3—atopic dermatitis	3.04e-05	0.00458	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCR3—atopic dermatitis	2.98e-05	0.00448	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL22—atopic dermatitis	2.97e-05	0.00448	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL22—atopic dermatitis	2.96e-05	0.00446	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCL27—atopic dermatitis	2.92e-05	0.00439	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL22—atopic dermatitis	2.91e-05	0.00438	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CCR3—atopic dermatitis	2.9e-05	0.00436	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCL27—atopic dermatitis	2.85e-05	0.0043	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	2.82e-05	0.00425	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CCR5—atopic dermatitis	2.81e-05	0.00423	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	2.76e-05	0.00416	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—NPS—atopic dermatitis	2.71e-05	0.00408	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—TAC1—atopic dermatitis	2.71e-05	0.00408	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCR3—atopic dermatitis	2.66e-05	0.00401	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—TAC1—atopic dermatitis	2.65e-05	0.004	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—NPS—atopic dermatitis	2.65e-05	0.004	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL27—atopic dermatitis	2.65e-05	0.00399	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL27—atopic dermatitis	2.64e-05	0.00397	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCR3—atopic dermatitis	2.63e-05	0.00396	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—CASP8—atopic dermatitis	2.62e-05	0.00394	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCR3—atopic dermatitis	2.6e-05	0.00392	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL27—atopic dermatitis	2.59e-05	0.0039	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—NPS—atopic dermatitis	2.58e-05	0.00389	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—TAC1—atopic dermatitis	2.58e-05	0.00389	CbGpPWpGaD
Nadolol—ADRB1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.55e-05	0.00385	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCR3—atopic dermatitis	2.53e-05	0.00381	CbGpPWpGaD
Nadolol—ADRB2—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	2.5e-05	0.00376	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.43e-05	0.00366	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—IL5—atopic dermatitis	2.4e-05	0.00362	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	2.38e-05	0.00358	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL17—atopic dermatitis	2.38e-05	0.00358	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL17—atopic dermatitis	2.36e-05	0.00356	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—TAC1—atopic dermatitis	2.34e-05	0.00353	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—NPS—atopic dermatitis	2.34e-05	0.00353	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL17—atopic dermatitis	2.32e-05	0.0035	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCR3—atopic dermatitis	2.3e-05	0.00346	CbGpPWpGaD
Nadolol—ADRB3—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	2.23e-05	0.00336	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IFNG—atopic dermatitis	2.23e-05	0.00335	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.19e-05	0.0033	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL5—atopic dermatitis	2.18e-05	0.00328	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCL10—atopic dermatitis	2.15e-05	0.00324	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	2.14e-05	0.00323	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—KIF3A—atopic dermatitis	2.11e-05	0.00317	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCL10—atopic dermatitis	2.1e-05	0.00317	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—CXCL8—atopic dermatitis	2.07e-05	0.00312	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCL10—atopic dermatitis	2.05e-05	0.00308	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL1B—atopic dermatitis	1.99e-05	0.00299	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—IL2—atopic dermatitis	1.98e-05	0.00298	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	1.96e-05	0.00295	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL11—atopic dermatitis	1.92e-05	0.00288	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL11—atopic dermatitis	1.91e-05	0.00287	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CMA1—atopic dermatitis	1.91e-05	0.00287	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—FCER2—atopic dermatitis	1.89e-05	0.00284	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL11—atopic dermatitis	1.87e-05	0.00282	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCL10—atopic dermatitis	1.86e-05	0.0028	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCL5—atopic dermatitis	1.85e-05	0.00279	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—FCER2—atopic dermatitis	1.85e-05	0.00278	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCL5—atopic dermatitis	1.81e-05	0.00273	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—STAT6—atopic dermatitis	1.79e-05	0.0027	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CCL5—atopic dermatitis	1.76e-05	0.00265	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL22—atopic dermatitis	1.76e-05	0.00264	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCR3—atopic dermatitis	1.72e-05	0.00259	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL22—atopic dermatitis	1.72e-05	0.00259	CbGpPWpGaD
Nadolol—ADRB3—GPCR ligand binding—CXCL8—atopic dermatitis	1.7e-05	0.00256	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCR3—atopic dermatitis	1.68e-05	0.00253	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CCR5—atopic dermatitis	1.67e-05	0.00251	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CCR5—atopic dermatitis	1.63e-05	0.00246	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCL5—atopic dermatitis	1.6e-05	0.00241	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CCR5—atopic dermatitis	1.59e-05	0.00239	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL27—atopic dermatitis	1.56e-05	0.00236	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCR3—atopic dermatitis	1.56e-05	0.00235	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCR3—atopic dermatitis	1.55e-05	0.00234	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—NPS—atopic dermatitis	1.53e-05	0.00231	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—TAC1—atopic dermatitis	1.53e-05	0.00231	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL27—atopic dermatitis	1.53e-05	0.00231	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCR3—atopic dermatitis	1.53e-05	0.0023	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCR3—atopic dermatitis	1.5e-05	0.00226	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—TAC1—atopic dermatitis	1.5e-05	0.00226	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—NPS—atopic dermatitis	1.5e-05	0.00226	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCR3—atopic dermatitis	1.47e-05	0.00221	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CCR5—atopic dermatitis	1.44e-05	0.00217	CbGpPWpGaD
Nadolol—ABCB1—Allograft Rejection—TNF—atopic dermatitis	1.44e-05	0.00217	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	1.43e-05	0.00216	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—IL5—atopic dermatitis	1.42e-05	0.00215	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL17—atopic dermatitis	1.4e-05	0.00211	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—IL5—atopic dermatitis	1.39e-05	0.0021	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—NPS—atopic dermatitis	1.39e-05	0.0021	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—TAC1—atopic dermatitis	1.39e-05	0.0021	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NPS—atopic dermatitis	1.38e-05	0.00209	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—TAC1—atopic dermatitis	1.38e-05	0.00209	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL17—atopic dermatitis	1.37e-05	0.00207	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCR3—atopic dermatitis	1.36e-05	0.00206	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—TAC1—atopic dermatitis	1.36e-05	0.00205	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—NPS—atopic dermatitis	1.36e-05	0.00205	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCR3—atopic dermatitis	1.36e-05	0.00205	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCR3—atopic dermatitis	1.33e-05	0.00201	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	1.33e-05	0.002	CbGpPWpGaD
Nadolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.32e-05	0.00199	CbGpPWpGaD
Nadolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	1.29e-05	0.00195	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL5—atopic dermatitis	1.29e-05	0.00195	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	1.29e-05	0.00195	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL5—atopic dermatitis	1.29e-05	0.00194	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL5—atopic dermatitis	1.27e-05	0.00191	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—KIF3A—atopic dermatitis	1.25e-05	0.00188	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—KIF3A—atopic dermatitis	1.22e-05	0.00184	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCL10—atopic dermatitis	1.21e-05	0.00183	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCL10—atopic dermatitis	1.19e-05	0.00179	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CMA1—atopic dermatitis	1.13e-05	0.0017	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL11—atopic dermatitis	1.13e-05	0.0017	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL11—atopic dermatitis	1.11e-05	0.00167	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CMA1—atopic dermatitis	1.11e-05	0.00167	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCL10—atopic dermatitis	1.1e-05	0.00166	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCL10—atopic dermatitis	1.1e-05	0.00165	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCL10—atopic dermatitis	1.08e-05	0.00163	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—STAT6—atopic dermatitis	1.06e-05	0.0016	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCL5—atopic dermatitis	1.05e-05	0.00157	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—STAT6—atopic dermatitis	1.04e-05	0.00157	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCL5—atopic dermatitis	1.02e-05	0.00154	CbGpPWpGaD
Nadolol—ADRB1—GPCR ligand binding—CXCL8—atopic dermatitis	1.01e-05	0.00152	CbGpPWpGaD
Nadolol—ADRB2—GPCR ligand binding—CXCL8—atopic dermatitis	9.86e-06	0.00148	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—CXCL8—atopic dermatitis	9.6e-06	0.00145	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCL5—atopic dermatitis	9.5e-06	0.00143	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCL5—atopic dermatitis	9.45e-06	0.00142	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CCR5—atopic dermatitis	9.42e-06	0.00142	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCL5—atopic dermatitis	9.29e-06	0.0014	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—GLB1—atopic dermatitis	9.28e-06	0.0014	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCR3—atopic dermatitis	9.22e-06	0.00139	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CCR5—atopic dermatitis	9.21e-06	0.00139	CbGpPWpGaD
Nadolol—ADRB3—GPCR downstream signaling—IL2—atopic dermatitis	9.17e-06	0.00138	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCR3—atopic dermatitis	9.02e-06	0.00136	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	8.98e-06	0.00135	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—ADSL—atopic dermatitis	8.9e-06	0.00134	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NGF—atopic dermatitis	8.75e-06	0.00132	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—CXCL8—atopic dermatitis	8.71e-06	0.00131	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CCR5—atopic dermatitis	8.55e-06	0.00129	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CCR5—atopic dermatitis	8.51e-06	0.00128	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CCR5—atopic dermatitis	8.37e-06	0.00126	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL2—atopic dermatitis	8.33e-06	0.00125	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—TAC1—atopic dermatitis	8.22e-06	0.00124	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NPS—atopic dermatitis	8.22e-06	0.00124	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCR3—atopic dermatitis	8.06e-06	0.00121	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—TAC1—atopic dermatitis	8.04e-06	0.00121	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NPS—atopic dermatitis	8.04e-06	0.00121	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCR3—atopic dermatitis	7.89e-06	0.00119	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL5—atopic dermatitis	7.64e-06	0.00115	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL5—atopic dermatitis	7.48e-06	0.00113	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—NFKBIA—atopic dermatitis	7.22e-06	0.00109	CbGpPWpGaD
Nadolol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	7.11e-06	0.00107	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL10—atopic dermatitis	6.52e-06	0.000981	CbGpPWpGaD
Nadolol—ABCB1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	6.43e-06	0.000969	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL10—atopic dermatitis	6.37e-06	0.00096	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—CXCL8—atopic dermatitis	5.7e-06	0.000858	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCL5—atopic dermatitis	5.61e-06	0.000845	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—CXCL8—atopic dermatitis	5.57e-06	0.000839	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCL5—atopic dermatitis	5.49e-06	0.000826	CbGpPWpGaD
Nadolol—ADRB1—GPCR downstream signaling—IL2—atopic dermatitis	5.44e-06	0.00082	CbGpPWpGaD
Nadolol—ADRB2—GPCR downstream signaling—IL2—atopic dermatitis	5.32e-06	0.000802	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NGF—atopic dermatitis	5.19e-06	0.000782	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—CXCL8—atopic dermatitis	5.17e-06	0.000779	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—CXCL8—atopic dermatitis	5.15e-06	0.000775	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NGF—atopic dermatitis	5.08e-06	0.000765	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—CXCL8—atopic dermatitis	5.06e-06	0.000762	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CCR5—atopic dermatitis	5.05e-06	0.000761	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CCR5—atopic dermatitis	4.94e-06	0.000745	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL2—atopic dermatitis	4.94e-06	0.000744	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL2—atopic dermatitis	4.92e-06	0.000741	CbGpPWpGaD
Nadolol—ADRB3—Signaling by GPCR—IL6—atopic dermatitis	4.89e-06	0.000737	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL2—atopic dermatitis	4.83e-06	0.000728	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—MAPK8—atopic dermatitis	4.53e-06	0.000682	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—NFKBIA—atopic dermatitis	4.28e-06	0.000645	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—NFKBIA—atopic dermatitis	4.19e-06	0.000631	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—CXCL8—atopic dermatitis	3.06e-06	0.00046	CbGpPWpGaD
Nadolol—ABCB1—Metabolism—PPARA—atopic dermatitis	3.01e-06	0.000454	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—CXCL8—atopic dermatitis	2.99e-06	0.00045	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL2—atopic dermatitis	2.92e-06	0.00044	CbGpPWpGaD
Nadolol—ADRB1—Signaling by GPCR—IL6—atopic dermatitis	2.91e-06	0.000438	CbGpPWpGaD
Nadolol—ADRB3—Signaling Pathways—IL6—atopic dermatitis	2.89e-06	0.000436	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL2—atopic dermatitis	2.86e-06	0.00043	CbGpPWpGaD
Nadolol—ADRB2—Signaling by GPCR—IL6—atopic dermatitis	2.84e-06	0.000428	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—MAPK8—atopic dermatitis	2.69e-06	0.000405	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—MAPK8—atopic dermatitis	2.63e-06	0.000396	CbGpPWpGaD
Nadolol—ADRB1—Signaling Pathways—IL6—atopic dermatitis	1.72e-06	0.000258	CbGpPWpGaD
Nadolol—ADRB2—Signaling Pathways—IL6—atopic dermatitis	1.68e-06	0.000253	CbGpPWpGaD
